Nov 18, 2018 – High Risk/Recurrent/Advanced Prostate Cancer Group

Broad Institute record requests; inter institution tissue slide requests; old vs new samples for testing; liquid vs solid tumor tests; FDA’s pan-cancer approvals; what does precision medicine mean?; continued success with Zytiga; S.A.M. pro’s & con’s; muscle cramp solutions; how much upfront ADT for Gleason 9?; treating recurrent disease. Check the new keyword, transcript function